Previous Chapter: Appendix B: Workshop Agenda
Suggested Citation: "Appendix C: Registered Attendees." National Academies of Sciences, Engineering, and Medicine. 2015. Enabling Discovery, Development, and Translation of Treatments for Cognitive Dysfunction in Depression: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/21745.

C

Registered Attendees

Patricia Areán

University of California, San Francisco

Deanna Barch

Washington University of St. Louis

Chanel Barnes

Common Health ACTION

Mitchell Belgin

Washington Square Integrative Psychiatry

Eva Bøge

H. Lundbeck A/S

Silvana Borges

Food and Drug Administration

Lizbet Boroughs

American Psychiatric Association

Christopher Bowie

Queen’s University

Linda Brady

National Institute of Mental Health

Stephen Brannan

Takeda Pharmaceuticals International, Inc.

Daniel Burch

Pharmaceutical Product Development

June Cai

Walter Reed National Military Medical Center

Rosa Canet-Aviles

Foundation for the National

Institutes of Health

C. Thomas Caskey

Baylor College of Medicine

Suggested Citation: "Appendix C: Registered Attendees." National Academies of Sciences, Engineering, and Medicine. 2015. Enabling Discovery, Development, and Translation of Treatments for Cognitive Dysfunction in Depression: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/21745.

Allen Egon Cholakian

IRDF Project

Harvard/Columbia

Michael Christensen

H. Lundbeck A/S

Bruce Cuthbert

National Institute of Mental Health

Nicholas DeMartinis

Pfizer Inc.

Kristin D’Onofrio

Takeda Pharmaceuticals International, Inc.

Martin Duenas

Leidos

Amit Etkin

Stanford University

Jennifer Evans

National Institutes of Health

Tiffany Farchione

Food and Drug Administration

Maurizio Fava

Massachusetts General Hospital

Rebecca Fitch

Department of Education/Office for Civil Rights

Scott Fogerty

Epistem

Mark Gorman

Member of the Public

Michael Green

University of California, Los Angeles

Catherine Harmer

University of Oxford

Philip Harvey

University of Miami Miller School of Medicine

Renee Heese

Pfizer Inc.

Mi Hillefors

National Institute of Mental Health

Thomas Insel

National Institute of Mental Health

William Jacobson

Takeda Development Center Americas

Judith Jaeger

CognitionMetrics, LLC

Charles Jeck

Physician

Suggested Citation: "Appendix C: Registered Attendees." National Academies of Sciences, Engineering, and Medicine. 2015. Enabling Discovery, Development, and Translation of Treatments for Cognitive Dysfunction in Depression: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/21745.

Peter Kaskan

National Institute of Mental Health

Gary Kay

Cognitive Research Corporation

Richard Keefe

Duke University Medical Center

Noam Keren

National Academy of Sciences

Inhwa Kim

American Association for the Advancement of Science

Center for Science, Technology, and Security Policy

Lawrence Klusman

Walter Reed National Military Medical Center

Manasi Kumar

University of Nairobi/University College London

Ian Laquian

Takeda Pharmaceuticals

Thomas Laughren

Laughren Psychopharm Consulting, LLC

Alan Leshner

American Association for the Advancement of Science (Emeritus)

Sheldon Levin

University of California, San Francisco

Elin Lof

H. Lundbeck A/S

Søren Lophaven

Lundbeck, LLC

Glenn Mannheim

Food and Drug Administration

Daniel Mathews

Lundbeck, LLC

Shelly Menolascino

Shelly Menolascino, M.D., LLC

Nivedita Mohanty

National Science Foundation

Randall Morrison

Janssen Research & Development

Andrew Nierenberg

Massachusetts General Hospital

George Nomikos

Takeda Pharmaceuticals

Suggested Citation: "Appendix C: Registered Attendees." National Academies of Sciences, Engineering, and Medicine. 2015. Enabling Discovery, Development, and Translation of Treatments for Cognitive Dysfunction in Depression: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/21745.

Christina Kurre Olsen

H. Lundbeck A/S

Joseph Palumbo

Mitsubishi Tanabe Pharma Development America Inc.

Atul Pande

Tal Medical

Jonathon Parker

Takeda Pharmaceuticals

Vanessa Perez

Takeda Pharmaceuticals

Diego Pizzagalli

Harvard Medical School & McLean Hospital

Jorge Quiroz

Roche

Juan Ruiz

Nestlé Health Science-Pamlab

Judith Rumsey

National Institute of Mental Health

Barbara Sahakian

University of Cambridge

Joanna Sambor

Takeda Pharmaceuticals

Sara Sarkey

Takeda Pharmaceuticals

Eugenia Schenecker

George Washington University

Dana Schloesser

Office of Behavioral and Social Sciences Research

Mary Smith

HH

David Sommers

National Institute of Mental Health

Jonathan Sporn

Pfizer Inc.

Tine Bryan Stensbol

H. Lundbeck A/S

Hedley Stickell

Takeda Pharmaceuticals

Luke Stoeckel

National Institute of Diabetes and Digestive and Kidney Diseases

Jed Strode

Belmore Services

Blerta Sulhasi

School-based Psychological Services Program

Dapo Tomori

Takeda Pharmaceuticals

Suggested Citation: "Appendix C: Registered Attendees." National Academies of Sciences, Engineering, and Medicine. 2015. Enabling Discovery, Development, and Translation of Treatments for Cognitive Dysfunction in Depression: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/21745.

Madhukar Trivedi

University of Texas Southwestern Medical Center

Uma Vaidyanathan

National Institute of Mental Health

Theresa Vera

Takeda Pharmaceuticals

Torbjörn Waerner

H. Lundbeck A/S

Molly Wagster

National Institute on Aging

Philip Wang

National Institute of Mental Health

Sheldon Weinberg

The CDM Group, Inc.

Cole Werble

Prevision Policy

Jerry Yang

Pfizer Inc.

Teresa Yang

Takeda Pharmaceuticals

Jing Zhang

Food and Drug Administration

Stevin Zorn

Lundbeck Research USA

Suggested Citation: "Appendix C: Registered Attendees." National Academies of Sciences, Engineering, and Medicine. 2015. Enabling Discovery, Development, and Translation of Treatments for Cognitive Dysfunction in Depression: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/21745.

This page intentionally left blank.

Suggested Citation: "Appendix C: Registered Attendees." National Academies of Sciences, Engineering, and Medicine. 2015. Enabling Discovery, Development, and Translation of Treatments for Cognitive Dysfunction in Depression: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/21745.
Page 73
Suggested Citation: "Appendix C: Registered Attendees." National Academies of Sciences, Engineering, and Medicine. 2015. Enabling Discovery, Development, and Translation of Treatments for Cognitive Dysfunction in Depression: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/21745.
Page 74
Suggested Citation: "Appendix C: Registered Attendees." National Academies of Sciences, Engineering, and Medicine. 2015. Enabling Discovery, Development, and Translation of Treatments for Cognitive Dysfunction in Depression: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/21745.
Page 75
Suggested Citation: "Appendix C: Registered Attendees." National Academies of Sciences, Engineering, and Medicine. 2015. Enabling Discovery, Development, and Translation of Treatments for Cognitive Dysfunction in Depression: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/21745.
Page 76
Suggested Citation: "Appendix C: Registered Attendees." National Academies of Sciences, Engineering, and Medicine. 2015. Enabling Discovery, Development, and Translation of Treatments for Cognitive Dysfunction in Depression: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/21745.
Page 77
Suggested Citation: "Appendix C: Registered Attendees." National Academies of Sciences, Engineering, and Medicine. 2015. Enabling Discovery, Development, and Translation of Treatments for Cognitive Dysfunction in Depression: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/21745.
Page 78
Subscribe to Email from the National Academies
Keep up with all of the activities, publications, and events by subscribing to free updates by email.